• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 MYC 的模块化合成转录阻遏物来自 bHLH DNA 结合域。

Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains.

机构信息

Department of Chemistry, University of Chicago, Chicago, IL, USA.

Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, USA.

出版信息

Nat Biotechnol. 2023 Apr;41(4):541-551. doi: 10.1038/s41587-022-01504-x. Epub 2022 Oct 27.

DOI:10.1038/s41587-022-01504-x
PMID:36302987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10392954/
Abstract

Despite unequivocal roles in disease, transcription factors (TFs) remain largely untapped as pharmacologic targets due to the challenges in targeting protein-protein and protein-DNA interactions. Here we report a chemical strategy to generate modular synthetic transcriptional repressors (STRs) derived from the bHLH domain of MAX. Our synthetic approach yields chemically stabilized tertiary domain mimetics that cooperatively bind the MYC/MAX consensus E-box motif with nanomolar affinity, exhibit specificity that is equivalent to or beyond that of full-length TFs and directly compete with MYC/MAX protein for DNA binding. A lead STR directly inhibits MYC binding in cells, downregulates MYC-dependent expression programs at the proteome level and inhibits MYC-dependent cell proliferation. Co-crystallization and structure determination of a STR:E-box DNA complex confirms retention of DNA recognition in a near identical manner as full-length bHLH TFs. We additionally demonstrate structure-blind design of STRs derived from alternative bHLH-TFs, confirming that STRs can be used to develop highly specific mimetics of TFs targeting other gene regulatory elements.

摘要

尽管转录因子(TFs)在疾病中具有明确的作用,但由于靶向蛋白-蛋白和蛋白-DNA 相互作用的挑战,它们在很大程度上仍未被开发为药物靶点。在这里,我们报告了一种从 MAX 的 bHLH 结构域生成模块化合成转录抑制剂(STRs)的化学策略。我们的合成方法产生了化学稳定的三级结构模拟物,这些模拟物以纳摩尔亲和力协同结合 MYC/MAX 共有 E 盒基序,具有与全长 TF 相当或更高的特异性,并直接与 MYC/MAX 蛋白竞争 DNA 结合。一种先导 STR 可直接抑制细胞中 MYC 的结合,下调蛋白质组水平的 MYC 依赖性表达程序,并抑制 MYC 依赖性细胞增殖。STR:E 盒 DNA 复合物的共结晶和结构测定证实了 DNA 识别的保留方式与全长 bHLH TF 非常相似。我们还证明了源自其他 bHLH-TFs 的 STR 的无结构设计,证实了 STR 可用于开发针对其他基因调控元件的高特异性 TF 模拟物。

相似文献

1
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains.靶向 MYC 的模块化合成转录阻遏物来自 bHLH DNA 结合域。
Nat Biotechnol. 2023 Apr;41(4):541-551. doi: 10.1038/s41587-022-01504-x. Epub 2022 Oct 27.
2
Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.Myc与λ阻遏物-HLH结构域融合体相互作用特异性的分析。
J Mol Biol. 1995 May 5;248(3):541-50. doi: 10.1006/jmbi.1995.0241.
3
Design and properties of a Myc derivative that efficiently homodimerizes.一种能有效同源二聚化的Myc衍生物的设计与特性
Oncogene. 1998 Nov 12;17(19):2463-72. doi: 10.1038/sj.onc.1202199.
4
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.Max:一种螺旋-环-螺旋拉链蛋白,可与Myc形成序列特异性DNA结合复合物。
Science. 1991 Mar 8;251(4998):1211-7. doi: 10.1126/science.2006410.
5
Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.Myc和Max介导的转录激活:侧翼序列在体内将激活作用靶向至一部分CACGTG基序。
EMBO J. 1993 Dec 15;12(13):5075-82. doi: 10.1002/j.1460-2075.1993.tb06201.x.
6
Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.Myc螺旋-环-螺旋/亮氨酸拉链突变体的基因调控特性:酵母中依赖Max的DNA结合和转录激活与转化能力相关。
Oncogene. 1993 Jul;8(7):1849-55.
7
Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.Mga,一种与Max相互作用的双特异性转录因子,含有一个T结构域DNA结合基序。
EMBO J. 1999 Dec 15;18(24):7019-28. doi: 10.1093/emboj/18.24.7019.
8
Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.用在大肠杆菌中表达的重组全长蛋白重建E盒结合Myc:Max复合物。
Protein Expr Purif. 2004 Apr;34(2):215-22. doi: 10.1016/j.pep.2003.11.021.
9
X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.Myc-Max和Mad-Max识别DNA的X射线结构。原癌基因转录因子调控的分子基础。
Cell. 2003 Jan 24;112(2):193-205. doi: 10.1016/s0092-8674(02)01284-9.
10
DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.Myc/Max/Mad网络复合物与含有两个E盒元件的寡核苷酸的DNA结合:c-Myc/Max异二聚体不协同结合DNA。
Biol Chem. 1999 Sep;380(9):1121-6. doi: 10.1515/BC.1999.140.

引用本文的文献

1
Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy.利用基于c-MYC的基因回路平台重编程肿瘤微环境以增强特异性癌症免疫治疗。
Nat Commun. 2025 Aug 27;16(1):7983. doi: 10.1038/s41467-025-63377-3.
2
Proteomimetic Strategy for the Modulation of Intrinsically Disordered Protein MYC.用于调节内在无序蛋白MYC的拟蛋白质组学策略
J Am Chem Soc. 2025 Apr 23;147(16):13296-13302. doi: 10.1021/jacs.4c18144. Epub 2025 Apr 8.
3
Chemical evolution of ASO-like DNAzymes for effective and extended gene silencing in cells.用于细胞中有效且持久基因沉默的类反义寡核苷酸脱氧核酶的化学进化
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf144.
4
Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering.超越小分子:通过蛋白质工程推进针对MYC的癌症治疗。
Transcription. 2025 Feb;16(1):67-85. doi: 10.1080/21541264.2025.2453315. Epub 2025 Jan 29.
5
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.用设计肽模拟物和合成生物制剂攻克不可成药靶点。
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
6
Family-Wide Photoproximity Profiling of Integrin Protein Social Networks in Cancer.癌症中整合素蛋白社交网络的全家族光邻近分析
bioRxiv. 2024 Sep 22:2024.09.18.613588. doi: 10.1101/2024.09.18.613588.
7
Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC.双MYC的开发:一种能有效抑制致癌转录因子MYC的可穿透细胞的合成微型蛋白质。
Angew Chem Int Ed Engl. 2025 Jan 21;64(4):e202416082. doi: 10.1002/anie.202416082. Epub 2024 Nov 6.
8
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors.用合成转录抑制因子直接抑制肿瘤缺氧反应。
Nat Chem Biol. 2025 Feb;21(2):247-255. doi: 10.1038/s41589-024-01716-z. Epub 2024 Aug 30.
9
Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions.阻断剂-SELEX:一种用于开发破坏不可成药转录因子相互作用的抑制性适配体的结构导向策略。
Nat Commun. 2024 Aug 8;15(1):6751. doi: 10.1038/s41467-024-51197-w.
10
Site-Specific Acetylation of the Transcription Factor Protein Max Modulates Its DNA Binding Activity.转录因子蛋白Max的位点特异性乙酰化调节其DNA结合活性。
ACS Cent Sci. 2024 Jun 12;10(6):1295-1303. doi: 10.1021/acscentsci.4c00686. eCollection 2024 Jun 26.

本文引用的文献

1
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.去除癌症中的 Myc:直接抑制 c-Myc 的治疗策略。
Mol Cancer. 2021 Jan 4;20(1):3. doi: 10.1186/s12943-020-01291-6.
2
De novo development of proteolytically resistant therapeutic peptides for oral administration.口服应用的新型抗蛋白水解治疗性肽的开发。
Nat Biomed Eng. 2020 May;4(5):560-571. doi: 10.1038/s41551-020-0556-3. Epub 2020 May 11.
3
Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.基于 Mxd1 的小分子蛋白抑制 Myc 转录活性。
FEBS Lett. 2020 May;594(10):1467-1476. doi: 10.1002/1873-3468.13759. Epub 2020 Mar 11.
4
Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.奥莫米星揭示了抑制 MYC 癌基因的新机制。
Mol Cell Biol. 2019 Oct 28;39(22). doi: 10.1128/MCB.00248-19. Print 2019 Nov 15.
5
Sequence specific suppression of androgen receptor-DNA binding in vivo by a Py-Im polyamide.Py-Im 聚酰胺体内特异性抑制雄激素受体-DNA 结合
Nucleic Acids Res. 2019 May 7;47(8):3828-3835. doi: 10.1093/nar/gkz153.
6
Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide.基于 RpoN 的被钉肽抑制细菌基因转录。
Cell Chem Biol. 2018 Sep 20;25(9):1059-1066.e4. doi: 10.1016/j.chembiol.2018.05.007. Epub 2018 Jun 7.
7
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma.转录因子激活蛋白 4 是合成致死的,也是 MYCN 扩增神经母细胞瘤的主要调节因子。
Oncogene. 2018 Oct;37(40):5451-5465. doi: 10.1038/s41388-018-0326-9. Epub 2018 Jun 7.
8
Engineered protein scaffolds as leads for synthetic inhibitors of protein-protein interactions.工程化蛋白支架作为蛋白质-蛋白质相互作用合成抑制剂的先导物。
Curr Opin Chem Biol. 2018 Jun;44:16-22. doi: 10.1016/j.cbpa.2018.05.013. Epub 2018 May 24.
9
Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models.具有疗效的订书钉状、长效胰高血糖素样肽 2 类似物在葡聚糖硫酸钠诱导的小鼠结肠炎模型中的应用。
J Med Chem. 2018 Apr 12;61(7):3218-3223. doi: 10.1021/acs.jmedchem.7b00768. Epub 2018 Mar 23.
10
The Human Transcription Factors.人类转录因子。
Cell. 2018 Feb 8;172(4):650-665. doi: 10.1016/j.cell.2018.01.029.